Read the full annotation for Betaserc 24 mg. Information regarding indications, side effects, and administration rules
Active substance: 24 mg Betahistine dihydrochloride.
Excipients: Microcrystalline cellulose, maize starch, colloidal anhydrous silica, tartrazine dye, povidone, purified talc, magnesium stearate, sodium starch glycolate.
Other preparations for the treatment of nervous system diseases. Antivertigo agent. Betahistine.
Meniere's syndrome, characterized by a triad of symptoms: dizziness (vertigo), accompanied by nausea and vomiting, tinnitus (ringing in the ears), and progressive hearing loss.
Symptomatic treatment of vestibular vertigo.
Take 1 tablet twice a day during or immediately after a meal.
Daily dose: 8-24 mg, divided into 2 or 3 doses.
Treatment is long-term; the best results are achieved after several months.
Nausea, dyspepsia, headache, hypersensitivity reactions (including Quincke's edema), skin rash and itching, urticaria, abdominal pain, bloating.
Hypersensitivity to any component of the preparation;
Pheochromocytoma;
Gastric and duodenal ulcer disease in the acute phase;
Bronchial asthma;
Pregnancy and breastfeeding period;
Under 18 years of age.
Do not prescribe during pregnancy without consulting a doctor.
Breastfeeding must be discontinued before taking Betahistine.
Does not affect the ability to drive or use other mechanisms.
Symptoms: Nausea, drowsiness, moderately pronounced abdominal pain.
Treatment: Symptomatic and supportive therapy is required.
Blue, round tablets with a score line on one side. 10 tablets in a contour cell aluminum foil package. 6 contour cell packages along with instructions for use are placed in a cardboard box.
Store in a cool, dark, dry place, out of reach of children.
2 years.
Dispensed by prescription.
